Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 4 34-4, 1996, Pages

  Fattinger, Karin E ^b   Verotta, Davide ^b   Porchet, Hervé C ^b   Munafo, Alain ^b   Le Cotonnec, Jean Yves ^b   Sheiner, Lewis B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

compartmental control system; Gonadotropin releasing hormone antagonist; luteinizing hormone

Indexed keywords

GONADORELIN ANTAGONIST; ITURELIX; LUTEINIZING HORMONE; TESTOSTERONE;

ARTICLE; CIRCADIAN RHYTHM; COMPARTMENT MODEL; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE RELEASE; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; TESTOSTERONE SYNTHESIS;

EID: 0029973997     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.4.e775     Document Type: Article

References (23)

1. Akaike, H. A new look at the statistical model identification. IEEE Trans. Automat. Contr. 19: 716-723, 1974.
2. Bagatell, C. J., P. M. Conn, and W. J. Bremner. Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men. Fertil. Steril., 60. 680-685, 1993.
3. Bates, D. M., and D. G. Watts. Nonlinear Regression Analysis and Its Applications. New York: Wiley, 1988, p. 205.
4. Beal, S. L., and L. B. Sheiner. NONMEM Users Guides. San Francisco, CA: Univ. of California San Francisco NONMEM Project Group, 1992.
5. Bird, C. E., W. Finnis, K. Boroomand, J. Murphy, and A. F. Clark. Kinetics of testosterone metabolism in normal postmenopausal women with breast cancer. Steroids 32: 323-335, 1978.
6. Carson, E. R., C. Cobelli, and L. Finkelstein. The Mathematical Modeling of Metabolic and Endocrine Systems. New York: Wiley, 1982.
7. Danforth, D. B., R. F. Williams, K. Gordon, and G. D. Hodgen. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. I. In vitro studies on mechanism of action. Endocrinology 128: 2036-2040, 1991.
8. DeBoor, C. A Practical Guide to Splines. New York: Springer-Verlag, 1978.
9. Edelstein, M. C., K. Gordon, R. F. Williams, D. R. Danforth, and G. D. Hodgen. Single dose long-term suppression of testosterone secretion by a gonadotropin-releasing hormone antagonist (antide) in male monkeys. Contraception 42: 209-214, 1990.
10. Gordon, K., F. Irianna, and G. D. Hodgen. Management of pituary function via gonadotropin releasing hormone (GnRH) antagonists, including ovulation induction by co-administration of either gonadotropins or pulsatile GnRH. Hum. Reprod. Eynsham. 8, Suppl 2: 204-209, 1993.
11. Jacquez, J. A. Compartmental Analysis in Biology and Medicine. Amsterdam: Elsevier, 1972.
12. Klingmuller, D., and H. U. Schweikert. Gonadotropin-releasing hormone: physiological and endocrinological aspects. Recent Results Cancer Res. 124: 1-6, 1992.
13. Li, S. L., B. Vuagnat, N. M. Gruaz, A. Eshkol, P. C. Sizonenko, and M. L. Aubert. Binding kinetics of the long-acting gonadotropin-releasing hormone (GnRH) antagonist antide to rat pituitary GnRH receptors. Endocrinology 135: 45-52, 1994.
14. Ljungqvist, A., D.-M. Feng, W. Hook, Z.-X. Shen, C. Boweres, and K. Folkers. Antide and related antagonists of luteinizing hormone release with long oral activity. Proc. Nat. Acad. Sci. USA 85: 8236-8240, 1988.
15. Miyatake, A., Y. Morimoto, T. Oishi, N. Hanaski, Y. Sugita, S. Iijima, Y. Teshima, Y. Hishikawa, and Y. Yamamura. Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin and cortisol in normal men. J. Clin. Endocrinol. Metab. 51: 1365-1371, 1980.
16. Porchet, H. C., J. Y. leCottonec, B. Neuteboom, S. Canali, and G. Zanolo. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J. Clin. Endocrinol. Metab. 80: 667-673, 1995.
17. Sheiner, L. B., and S. Beal. Bayesian individualisation of pharmacokinetics: simple implementation and comparison with non-bayesian methods. J. Pharm. Sci. 71: 1344-1348, 1982.
18. Troconiz, I. F., L. B. Sheiner, and D. Verotta. Semiparametric models for antagonistic drug interactions. J. Appl. Physiol. 76: 2224-2233, 1994
19. Veldhuis, J. D., J. C. King, R. J. Urban, A. D. Rogol, W. S. Evans, L. A. Kolp, and M. J. Johnson. Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone. J. Clin. Endocrinol. Metab. 65: 929-941, 1987.
20. Veldhuis, J. D., R. J. Urban, and M. L. Dufau. Evidence that androgen negative feedback regulates hypothalamic gonadotropin-releasing hormone impulse strength and the burst-like secretion of biologically active luteinizing hormone in men. J. Clin. Endocrinol. Metab. 74: 1227-1235, 1992.
21. Verotta, D., L. B. Sheiner, W. F. Ebling, and D. R. Stanski. A semiparametric approach to physiological flow models. J. Pharmacokinet. Biopharm. 17: 463-491, 1989.
22. Vickery, B. H. Biological actions of synthetic analogs of luteinizing hormone-releasing hormone. In: Peptides, Peptoids, And Proteins, edited by P. D. Garzone, W. A. Colburn, and M. Mokotoff. Cincinnati, OH: Harney Whitney Books, 1991, p. 41-49.
23. Wilson, J. D., and D. W. Foster. Textbook of Endocrinology. Philadelphia, PA: Saunders, 1985, p. 262-269.